These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25239365)

  • 1. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.
    Quillin RC; Wilson GC; Sutton JM; Hanseman DJ; Paterno F; Cuffy MC; Paquette IM; Diwan TS; Woodle ES; Abbott DE; Shah SA
    Surgery; 2014 Oct; 156(4):1049-56. PubMed ID: 25239365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
    Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H
    Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
    Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
    Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
    Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.
    Agopian VG; Kaldas FM; Hong JC; Whittaker M; Holt C; Rana A; Zarrinpar A; Petrowsky H; Farmer D; Yersiz H; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2012 Oct; 256(4):624-33. PubMed ID: 22964732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Iranian Patients.
    Eshraghian A; Nikeghbalian S; Dehghani M; Shamsaeefar A; Kazemi K; Nikoopour H; Eghlimi H; Gholami S; Salahi H; Malek-Hosseini SA
    Exp Clin Transplant; 2022 May; 20(5):487-494. PubMed ID: 31580238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
    Calzadilla-Bertot L; Jeffrey GP; Jacques B; McCaughan G; Crawford M; Angus P; Jones R; Gane E; Munn S; Macdonald G; Fawcett J; Wigg A; Chen J; Fink M; Adams LA
    Liver Transpl; 2019 Jan; 25(1):25-34. PubMed ID: 30609187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Share 35 Policy on Liver Transplantation Outcomes for Patients With Nonalcoholic Steatohepatitis.
    Zhang Y; Boktour MR
    Prog Transplant; 2019 Sep; 29(3):248-253. PubMed ID: 31146627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases.
    Kennedy C; Redden D; Gray S; Eckhoff D; Massoud O; McGuire B; Alkurdi B; Bloomer J; DuBay DA
    HPB (Oxford); 2012 Sep; 14(9):625-34. PubMed ID: 22882200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Center Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Recurrence in Recipients of Liver Transplant for Treatment of Nonalcoholic Steatohepatitis Cirrhosis.
    Matsuoka L; Chotai PN; Slaughter J; Campbell K; Kerr A; Hamel S; Garza C; Alexopoulos SP; Scanga A
    Exp Clin Transplant; 2022 Feb; 20(2):150-156. PubMed ID: 35037605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extended criteria donors in liver transplantation for nonalcoholic steatohepatitis.
    Dimou FM; Mehta HB; Adhikari D; Harland RC; Riall TS; Kuo YF
    Surgery; 2016 Dec; 160(6):1533-1543. PubMed ID: 27554622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
    Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
    Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.